FEB 01, 2017 5:13 PM PST

New Details About how Cells Change as Tumors Develop

WRITTEN BY: Carmen Leitch

Understanding the physiology that underlies the transition as a cell moves from being healthy to being cancerous is a critical part of treating or halting the spread of cancer effectively. Researchers have linked the appearance of a large number of vesicles moving out of tumor cells and small but detectable changes in metabolism portend major events. These small changes in the microenvironment of a tumor could be paving the way for the metastasis of cancer. Powerful optical technology has now enabled researchers to visualize the changes that cells undergo as a tumor grows, without the use of tags of dyes; the work was reported in Science Advances. 

A constellation of vesicles, tiny cellular transport packages seen here as blue dots, are released by cancer cells into the surrounding tissue. Illinois researchers found that these vesicles, coupled with molecular changes in metabolism, can signal big changes in the tissue around tumors. / Credit: Image courtesy of Stephen Boppart and Haohua Tu University of Illinois

The investigators were able to get a look at what was happening at the molecular level at five different time points in rat and human samples. They utilized specific wavelengths of light to illuminate the molecular and structural composition of tissue without manipulation, and combined images made using each wavelength to create a total picture of cellular events. This technique showed that a large number of vesicles move out before the major events of blood vessel growth and the  spread of cancer to nearby cells. These vesicles could be part of a causal event, suggest the researchers.

"We're starting to connect the dots here. This is the first time all of these pieces have been looked at together. No one's been able to visualize the tissue this way and see the changes dynamically," said the leader of this work, Dr. Stephen Boppart, a Professor of Electrical and Computer engineering and of Bioengineering at the University of Illinois, and a medical doctor.

"This paper is important because it connects the microscopic scale - the molecular and vesicle scale -- with the larger-scale events in the tissue," commented first author Haohua Tu, a research scientist at the Beckman Institute for Advanced Science and Technology at Illinois. "Also, this is the first time we've compared changes in metabolism and vesicle production, and we found that they are linked. Both are microscopic events, but their concurrence leads to a lot of large-scale changes associated with tumor progression. The conclusion is that the combination of these two signals early cancer development and should be a focus of cancer therapy, rather than only focusing on larger-scale events later."

The researchers also said that their work shows that cancer cells produce vesicles that influence the spread of cancer and change the microenvironment of a tumor.

"Often, when there is a tumor in one tissue, cells elsewhere have undergone changes because of that tumor," Boppart said. "Are all these changes happening because there was some sort of environmental carcinogen that caused tumors at different points? Or did the tumor give off vesicles that changed the microenvironment to prepare it for those later cells that metastasize?"

The investigators are hopeful that this work could lead to a new line of thinking in the approach to the treatment, detection and study of cancer. A portable imaging device like the one used by the researchers has been created for use on patients undergoing biopsies or operative interventions. It could be useful for the detection of heightened vesicle production in patients and it may indicate how aggressive a cancer is. The scientists are also wiring to determine the contents of these vesicles.

"We also know from other studies that these vesicles carry a lot of information about where they came from and where they're going," explained Boppart. "Imaging is great, but you have to know where to look. There's no way we can look at the whole body on the cellular level. But if we can take a drop of blood, scan it for cancer-related vesicles and know where they came from, then we know where to look for the tumor."

If you would like to know more about the research of Dr. Boppart, check out the video below, in which he provides an overview of how microscopy techniques give us a window in to the physiology of disease. 

 

Sources: AAAS/Eurekalert! via University of Illinois, Science Advances

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 08, 2019
Genetics & Genomics
DEC 08, 2019
Finding a Way to Treat Dangerous Protein Aggregates
The scientists are hopeful that this work will lead to new therapeutics for neurodegenerative disease....
DEC 15, 2019
Cell & Molecular Biology
DEC 15, 2019
Using a Bacterial Syringe to Deliver Proteins to Cells
Researchers want to use a pathogen's strategy for therapeutic purposes....
DEC 17, 2019
Cell & Molecular Biology
DEC 17, 2019
A New Tool for Assessing the Impact of Drugs on Single Cells
When scientists assess the impact of a treatment like a drug on cells, they usually generally rely on large populations of cells to find general trends....
DEC 25, 2019
Drug Discovery & Development
DEC 25, 2019
New Drug to Make Breast Cancer Treatment More Affordable
The US Food and Drug Administration has granted accelerated approval to new breast cancer drug, trastuzumab deruxtecan. The drug’s increasing recogni...
DEC 31, 2019
Genetics & Genomics
DEC 31, 2019
Should the Scientist Behind World's First Gene Edited Babies be in Prison?
He Jiankui, the scientist behind the world’s first gene-edited babies in 2018, has been sentenced to three years in prison by Chinese authorities for...
JAN 11, 2020
Neuroscience
JAN 11, 2020
Molecular Therapy to Self-Repair Nerve Cells
Neurodegenerative diseases such as Multiple Sclerosis (MS), Alzheimer's, and Huntington's Disease are predicated on damage to myelin on nerve cells...
Loading Comments...